{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T17:26:03Z","timestamp":1779384363017,"version":"3.53.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,3,14]],"date-time":"2013-03-14T00:00:00Z","timestamp":1363219200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s00213-013-3037-5","type":"journal-article","created":{"date-parts":[[2013,3,13]],"date-time":"2013-03-13T07:47:33Z","timestamp":1363160853000},"page":"321-333","source":"Crossref","is-referenced-by-count":17,"title":["Multiple nicotine training doses in mice as a basis for differentiating the effects of smoking cessation aids"],"prefix":"10.1007","volume":"228","author":[{"given":"Colin S.","family":"Cunningham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance R.","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,14]]},"reference":[{"key":"3037_CR1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s002130050188","volume":"129","author":"CJ Chandler","year":"1997","unstructured":"Chandler CJ, Stolerman IP (1997) Discriminative stimulus properties of the nicotinic agonist cytisine. Psychopharmacology 129:257\u2013264","journal-title":"Psychopharmacology"},{"key":"3037_CR2","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0022-3565(24)36376-1","volume":"280","author":"LE Chavez-Noriega","year":"1997","unstructured":"Chavez-Noriega LE, Crona JH, Washburn MS, Urrutia A, Elliott KJ, Johnson EC (1997) Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors h alpha2beta2, h alpha2beta4, h alphabeta2, h alpha3beta4, h alpha4beta2, h alpha4beta4 and h alpha7 expressed in Xenopus oocytes. J Pharmacol Exp Ther 280:346\u2013356","journal-title":"J Pharmacol Exp Ther"},{"key":"3037_CR3","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1021\/jm050069n","volume":"48","author":"JW Coe","year":"2005","unstructured":"Coe JW, Brooks PR, Vetelino MG, Wirtz MC, Arnold EP, Huang J, Sands SB, Davis TI, Lebel LA, Fox CB, Shrikhande A, Heym JH, Schaeffer E, Rollema H, Lu Y, Mansbach RS, Chambers LK, Rovetti CC, Schulz DW, Tingley FD 3rd, O\u2019Neill BT (2005) Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. J Med Chem 48:3474\u20133477","journal-title":"J Med Chem"},{"key":"3037_CR4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF02431526","volume":"96","author":"AC Collins","year":"1988","unstructured":"Collins AC, Romm E, Wehner JM (1988) Nicotine tolerance: an analysis of the time course of its development and loss in the rat. Psychopharmacology 96:7\u201314","journal-title":"Psychopharmacology"},{"key":"3037_CR5","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/0028-3908(80)90061-1","volume":"19","author":"FC Colpaert","year":"1980","unstructured":"Colpaert FC, Niemegeers CJ, Janssen PA (1980) Factors regulating drug cue sensitivity: the effect of training dose in fentanyl-saline discrimination. Neuropharmacology 19:705\u2013713","journal-title":"Neuropharmacology"},{"key":"3037_CR6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF00216050","volume":"96","author":"RM Craft","year":"1988","unstructured":"Craft RM, Howard JL (1988) Cue properties of oral and transdermal nicotine in the rat. Psychopharmacology 96:281\u2013284","journal-title":"Psychopharmacology"},{"key":"3037_CR7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejphar.2010.12.003","volume":"654","author":"CS Cunningham","year":"2011","unstructured":"Cunningham CS, McMahon LR (2011) The effects of nicotine, varenicline, and cytisine on schedule-controlled responding in mice: differences in \u03b14\u03b22 nicotinic receptor activation. Eur J Pharmacol 654:47\u201352","journal-title":"Eur J Pharmacol"},{"key":"3037_CR8","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1124\/jpet.112.193078","volume":"341","author":"CS Cunningham","year":"2012","unstructured":"Cunningham CS, Javors M, McMahon LR (2012) Pharmacologic characterization of a nicotine discriminative stimulus in rhesus monkeys. J Pharmacol Exp Ther 341:840\u2013849","journal-title":"J Pharmacol Exp Ther"},{"key":"3037_CR9","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1016\/S0028-3908(00)00130-1","volume":"39","author":"J Gommans","year":"2000","unstructured":"Gommans J, Stolerman IP, Shoaib M (2000) Antagonism of the discriminative and aversive stimulus properties of nicotine in C57BL\/6J mice. Neuropharmacology 39:2840\u20132847","journal-title":"Neuropharmacology"},{"key":"3037_CR10","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1523\/JNEUROSCI.5095-09.2010","volume":"30","author":"C Gotti","year":"2010","unstructured":"Gotti C, Guiducci S, Tedesco V, Corbioli S, Zanetti L, Moretti M, Zanardi A, Rimondini R, Mugnaini M, Clementi F, Chiamulera C, Zoli M (2010) Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2* receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement. J Neurosci 30:5311\u20135325","journal-title":"J Neurosci"},{"key":"3037_CR11","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.neuropharm.2010.01.013","volume":"58","author":"SR Grady","year":"2010","unstructured":"Grady SR, Drenan RM, Breining SR, Yohannes D, Wageman CR, Fedorov NB, McKinney S, Whiteaker P, Bencherif M, Lester HA, Marks MJ (2010) Structural differences determine the relative selectivity of nicotinic compounds for native alpha 4 beta 2*-, alpha 6 beta 2*-, alpha 3 beta 4*- and alpha 7-nicotine acetylcholine receptors. Neuropharmacology 58:1054\u20131066","journal-title":"Neuropharmacology"},{"key":"3037_CR12","volume-title":"Guide for the care and use of laboratory animals","author":"Institute for Laboratory Animal Research","year":"2011","unstructured":"Institute for Laboratory Animal Research (2011) Guide for the care and use of laboratory animals, 8th edn. Institute for Laboratory Animal Research, Division of Earth and Life Sciences, National Research Council, Washington, DC","edition":"8"},{"key":"3037_CR13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.neuropharm.2009.07.020","volume":"57","author":"KJ Jackson","year":"2009","unstructured":"Jackson KJ, Walters CL, Miles MF, Martin BR, Damaj MI (2009) Characterization of pharmacological and behavioral differences to nicotine in C57Bl\/6 and DBA\/2 mice. Neuropharmacology 57:347\u2013355","journal-title":"Neuropharmacology"},{"key":"3037_CR14","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1124\/jpet.111.182170","volume":"339","author":"EM Jutkiewicz","year":"2011","unstructured":"Jutkiewicz EM, Brooks EA, Kynaston AD, Rice KC, Woods JH (2011) Patterns of nicotinic receptor antagonism: nicotine discrimination studies. J Pharmacol Exp Ther 339:194\u2013202","journal-title":"J Pharmacol Exp Ther"},{"key":"3037_CR15","volume-title":"Pharmacologic analysis of drug-receptor interaction","author":"T Kenakin","year":"1997","unstructured":"Kenakin T (1997) Pharmacologic analysis of drug-receptor interaction. Lippincott Williams & Wilkins, New York"},{"key":"3037_CR16","volume-title":"A pharmacology primer: theory, application and methods","author":"T Kenakin","year":"2009","unstructured":"Kenakin T (2009) A pharmacology primer: theory, application and methods. Academic Press, San Diego"},{"key":"3037_CR17","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.pbb.2008.08.024","volume":"91","author":"MG LeSage","year":"2008","unstructured":"LeSage MG, Shelley D, Ross JT, Carroll FI, Corrigall WA (2008) Effects of the nicotinic receptor partial agonists varenicline and cytisine on the discriminative stimulus effects of nicotine in rats. Pharmacol Biochem Behav 91:461\u2013467","journal-title":"Pharmacol Biochem Behav"},{"key":"3037_CR18","first-page":"209","volume":"4","author":"EA Mariathasan","year":"1993","unstructured":"Mariathasan EA, Stolerman IP (1993) Overshadowing of nicotine discrimination in rats: a model for behavioural mechanisms of drug interactions? Behav Pharmacol 4:209\u2013215","journal-title":"Behav Pharmacol"},{"key":"3037_CR19","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1124\/mol.106.025130","volume":"70","author":"KB Mihalak","year":"2006","unstructured":"Mihalak KB, Carroll FI, Luetje CW (2006) Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. Mol Pharmacol 70:801\u2013805","journal-title":"Mol Pharmacol"},{"key":"3037_CR20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/BF00439274","volume":"81","author":"JA Pratt","year":"1983","unstructured":"Pratt JA, Stolerman IP, Garcha HS, Giardini V, Feyerabend C (1983) Discriminative stimulus properties of nicotine: further evidence for mediation at a cholinergic receptor. Psychopharmacology 81:54\u201360","journal-title":"Psychopharmacology"},{"key":"3037_CR21","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0028-3908(90)90022-J","volume":"29","author":"C Reavill","year":"1990","unstructured":"Reavill C, Walther B, Stolerman IP, Testa B (1990) Behavioural and pharmacokinetic studies on nicotine, cytisine and lobeline. Neuropharmacology 29:619\u2013624","journal-title":"Neuropharmacology"},{"key":"3037_CR22","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.neuropharm.2006.10.016","volume":"52","author":"H Rollema","year":"2007","unstructured":"Rollema H, Chambers LK, Coe JW, Glowa J, Hurst RS, Lebel LA, Lu Y, Mansbach RS, Mather RJ, Rovetti CC, Sands SB, Schaeffer E, Schulz DW, Tingley FD 3rd, Williams KE (2007) Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. Neuropharmacology 52:985\u2013994","journal-title":"Neuropharmacology"},{"key":"3037_CR23","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0028-3908(01)00194-0","volume":"42","author":"M Shoaib","year":"2002","unstructured":"Shoaib M, Gommans J, Morley A, Stolerman IP, Grailhe R, Changeux JP (2002) The role of nicotinic receptor beta-2 subunits in nicotine discrimination and conditioned taste aversion. Neuropharmacology 42:530\u2013539","journal-title":"Neuropharmacology"},{"key":"3037_CR24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/978-3-540-69248-5_11","volume":"192","author":"JW Smith","year":"2009","unstructured":"Smith JW, Stolerman IP (2009) Recognising nicotine: the neurobiological basis of nicotine discrimination. Handb Exp Pharmacol 192:295\u2013333","journal-title":"Handb Exp Pharmacol"},{"key":"3037_CR25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00213-006-0596-8","volume":"190","author":"JW Smith","year":"2007","unstructured":"Smith JW, Mogg A, Tafi E, Peacey E, Pullar IA, Szekeres P, Tricklebank M (2007) Ligands selective for alpha4beta2 but not alpha3beta4 or alpha7 nicotinic receptors generalise to the nicotine discriminative stimulus in the rat. Psychopharmacology 190:157\u2013170","journal-title":"Psychopharmacology"},{"key":"3037_CR26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF00429192","volume":"30","author":"IP Stolerman","year":"1973","unstructured":"Stolerman IP, Fink R, Jarvik ME (1973) Acute and chronic tolerance to nicotine measured by activity in rats. Psychopharmacology 30:329\u2013342","journal-title":"Psychopharmacology"},{"key":"3037_CR27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s002130050837","volume":"141","author":"IP Stolerman","year":"1999","unstructured":"Stolerman IP, Naylor C, Elmer GI, Goldberg SR (1999) Discrimination and self-administration of nicotine by inbred strains of mice. Psychopharmacology 141:297\u2013306","journal-title":"Psychopharmacology"},{"key":"3037_CR28","doi-asserted-by":"crossref","DOI":"10.1201\/9781420036107","volume-title":"Drug Synergism and Dose-Effect Data Analysis","author":"RJ Tallarida","year":"2000","unstructured":"Tallarida RJ (2000) Drug Synergism and Dose-Effect Data Analysis. Chapman Hall\/CRC Press, Boca Raton"},{"key":"3037_CR29","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0026-895X(25)13493-7","volume":"28","author":"WA Varanda","year":"1985","unstructured":"Varanda WA, Aracava Y, Sherby SM, VanMeter WG, Eldefrawi ME, Albuquerque EX (1985) The acetylcholine receptor of the neuromuscular junction recognizes mecamylamine as a noncompetitive antagonist. Mol Pharmacol 28:128\u2013137","journal-title":"Mol Pharmacol"},{"key":"3037_CR30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0091-3057(98)00262-7","volume":"63","author":"SA Varvel","year":"1999","unstructured":"Varvel SA, James JR, Bowen S, Rosecrans JA, Karan LD (1999) Discriminative stimulus (DS) properties of nicotine in the C57BL\/6 mouse. Pharmacol Biochem Behav 63:27\u201332","journal-title":"Pharmacol Biochem Behav"},{"key":"3037_CR31","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0022-3565(25)10968-3","volume":"261","author":"AM Young","year":"1992","unstructured":"Young AM, Masaki MA, Geula C (1992) Discriminative stimulus effects of morphine: effects of training dose on agonist and antagonist effects of mu opioids. J Pharmacol Exp Ther 261:246\u2013257","journal-title":"J Pharmacol Exp Ther"},{"key":"3037_CR32","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s002130050035","volume":"148","author":"L Zhang","year":"2000","unstructured":"Zhang L, Walker EA, Sutherland J 2nd, Young AM (2000) Discriminative stimulus effects of two doses of fentanyl in rats: pharmacological selectivity and effect of training dose on agonist and antagonist effects of mu opioids. Psychopharmacology 148:136\u2013145","journal-title":"Psychopharmacology"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-013-3037-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-013-3037-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-013-3037-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:24:25Z","timestamp":1745972665000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-013-3037-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,14]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["3037"],"URL":"https:\/\/doi.org\/10.1007\/s00213-013-3037-5","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,14]]}}}